Join our SVP of Research Stefan Lutz for a panel discussion on scaling RNA therapies and a presentation by Mathew Miller discussing the cost effectiveness of manufacturing siRNA duplexes with engineered dsRNA ligases at RNA Leaders next week. Several Codexians will be on the ground in San Diego for the conference. Message us here to set up a meeting with our team or stop by Booth #9 for an impromptu chat. Safe travels to everyone heading to San Diego ✈️ and we'll see you there! #RNALeaders #enzymeengineering #proteinengineering #RNAitherapeutics Stefan, Matt, Kevin Norrett, Britton Jimenez, Mark Hochstetler and Jean Shieh - have a great meeting!
Codexis, Inc.
Biotechnology Research
Redwood City, CA 18,120 followers
We deliver exquisite enzymes for the betterment of human health.
About us
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
- Website
-
http://www.codexis.com
External link for Codexis, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Redwood City, CA
- Type
- Public Company
- Founded
- 2002
- Specialties
- Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, RNA manufacturing, RNA detection, and Oligo synthesis
Locations
-
Primary
200 Penobscot Drive
Redwood City, CA 94063, US
Employees at Codexis, Inc.
-
Lata Sircar
Senior Finance Leader | Business Partner | Process Improvement | Change Management
-
Lauren Rose Musto
Helping biotechs share their vision with the world | LinkedIn Top Voice | Corporate Communications | Storytelling | Branding | Engagement | Advocacy…
-
David Smith
-
Antoinette Sero
Associate Scientist
Updates
-
Who is joining us in San Diego for #RNALeaders? Meet up with our Codexis team on the ground or join us for one of our two presentations on enzymatic synthesis for RNAi therapeutics. Hit the follow button for more info on our presence at RNA Leaders and our market-leading enzymatic synthesis capabilities. #proteinengineering #enzymeengineering #RNAitherapeutics
-
We're excited to share that today we issued our initial ESG disclosures aligned with the Sustainability Accounting Standards Board. You can read more in our press release: https://bit.ly/4dmXLAs #sustainability #ESG #governance #RNAitherapeutics
-
Today we issued our Q2 2024 financial results and provided a business update. Click below to read our press release and listen to our investor call beginning at 4:30 pm ET. Link: https://bit.ly/3LYGn8U #codexis #proteinengineering #enzymeenginering #rnaitherapeutics
-
We are excited to be attending and sponsoring the RNA Leaders Conference next month in San Diego! We'll have an entire team on the ground ready to chat all about our enzymatic synthesis capabilities. Want to meet up? Stop by Booth #9 or message us here to make an appointment. #RNALeaders #Codexis #proteinengineering #enzymeengineering #rnaitherapeutics
-
Codexis is reporting Q2 2024 financial results and providing a business update on Thursday, August 8th! Read our press release for all the details: https://lnkd.in/ef9B2HZr
-
We see incredible potential for enzymatic synthesis to support RNAi therapeutics manufacturing. To learn more, check out the interview our COO Kevin Norrett did with Genetic Engineering & Biotechnology News following our groundbreaking #TIDESUSA presentation last month. #proteinengineering #enzymeengineering #RNAi
Enzymes: A Better Option for Therapeutic Oligo Makers? An enzymatic oligonucleotide production platform may bypasses the challenges associated with traditional methods. GEN spoke with Kevin Norrett, COO at protein engineering company Codexis, Inc.
-
Following our groundbreaking #TIDESUSA presentation last month, Codexis Chief Operating Officer Kevin Norrett had a virtual sit down with Genetic Engineering & Biotechnology News to discuss RNAi therapeutics manufacturing. The resulting feature article highlights the need and urgency for another option to supplement traditional chemical manufacturing practices, which will face challenges of scale as more RNAi therapeutics make their way through the development process...there are of 450 of them in clinical trials right now! Click the link below for the full article discussing enzymatic synthesis for RNAi therapeutics. Link: https://lnkd.in/ej2uGzFc #proteinengineering #enzymeengineering #RNAitherapeutics #RNAi
Home
genengnews.com
-
Each quarter we host an activity that supports our Community corporate value. Sometimes this about our internal community as Codexians and strengthening our corporate culture. Other times, it's about supporting the local communities in which we work and live. Last week, we were thrilled to assemble 250 backpacks for rising kindergarten to 2nd grade students in our local community with the help of Family Giving Tree. The team at FGT set up a brilliant assembly line in our Boardroom and we had everything packed in about 90 minutes! We laughed, we bumped into each other, we smiled and then we said we wish we had more to do. If you're looking for a teambuilding activity in the Bay Area, definitely give L. Margarita Galindo MNA at FGT a call. Huge thanks to Vesna Mitchell, Michael Whitehorn and the Codexis Activities Committee for bringing this opportunity to us! #giveback #communityrelations #proteinengineering #enzymeengineering #rnai #RNAitherapeutics
-
It's the last day of #TIDESUSA! The Codexis crew is ready to talk all things enzyme engineering, ligation and RNAi therapeutics. Stop by Booth #628 to say hi and learn more! #proteinengineering #enzymeengineering #RNAi #RNAitherapeutics #ligase
Similar pages
Browse jobs
Stock
CDXS
NASDAQ
20 minutes delay
$2.74
-0.07 (-2.491%)
- Open
- 2.8
- Low
- 2.73
- High
- 2.84
Data from Refinitiv
See more info on